相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies
L. Rojas et al.
PHARMACOGENOMICS JOURNAL (2015)
The Role of Pharmacogenetics in the Disposition of and Response to Tacrolimus in Solid Organ Transplantation
Dennis A. Hesselink et al.
CLINICAL PHARMACOKINETICS (2014)
CYP3A5 and CYP3A4, but not ABCB1 polymorphisms affect tacrolimus dose-adjusted trough concentrations in kidney transplant recipients
Mateusz Kurzawski et al.
PHARMACOGENOMICS (2014)
Assessment of Four Methodologies (Microparticle Enzyme Immunoassay, Chemiluminescent Enzyme Immunoassay, Affinity Column-Mediated Immunoassay, and Flow Injection Assay-Tandem Mass Spectrometry) for Measuring Tacrolimus Blood Concentration in Japanese Liver Transplant Recipients
S. Hashi et al.
TRANSPLANTATION PROCEEDINGS (2014)
Pharmacogenetics and immunosuppressive drugs
Karolina Hronova et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2014)
The effect of ABCB1 C3435T polymorphism on pharmacokinetics of tacrolimus in liver transplantation: A meta-analysis
Yuan-Yuan Liu et al.
GENE (2013)
A search for new CYP3A4 variants as determinants of tacrolimus dose requirements in renal-transplanted patients
Beatriz Tavira et al.
PHARMACOGENETICS AND GENOMICS (2013)
DPYD IVS14+1G>A and 2846A>T genotyping for the prediction of severe fluoropyrimidine-related toxicity: a meta-analysis
Salvatore Terrazzino et al.
PHARMACOGENOMICS (2013)
Who are at risk for thromboembolism after arthroplasty? A systematic review and meta-analysis
Xindie Zhou et al.
THROMBOSIS RESEARCH (2013)
Concentration of tacrolimus and major metabolites in kidney transplant recipients as a function of diabetes mellitus and cytochrome P450 3A gene polymorphism
Shripad D. Chitnis et al.
XENOBIOTICA (2013)
The effect of CYP3A5 6986A>G and ABCB1 3435C>T on tacrolimus dose-adjusted trough levels and acute rejection rates in renal transplant patients: a systematic review and meta-analysis
Salvatore Terrazzino et al.
PHARMACOGENETICS AND GENOMICS (2012)
Impact of genetic polymorphisms on tacrolimus pharmacokinetics and the clinical outcome of renal transplantation
Guillermo Gervasini et al.
TRANSPLANT INTERNATIONAL (2012)
Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes (vol 49, pg 825, 2011)
Beatriz Tavira et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2011)
Influence of CYP3A5 polymorphism on tacrolimus maintenance doses and serum levels after renal transplantation: Age dependency and pharmacological interaction with steroids
Jorge R. Ferraris et al.
PEDIATRIC TRANSPLANTATION (2011)
Lower tacrolimus daily dose requirements and acute rejection rates in the CYP3A5 nonexpressers than expressers
Hui-Lin Tang et al.
PHARMACOGENETICS AND GENOMICS (2011)
Impact of CYP3A5 and CYP3A4 gene polymorphisms on dose requirement of calcineurin inhibitors, cyclosporine and tacrolimus, in renal allograft recipients of North India
Ranjana Singh et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2009)
STrengthening the REporting of Genetic Association Studies (STREGA) - An Extension of the STROBE Statement
Julian Little et al.
PLOS MEDICINE (2009)
CYP3A5 and CYP3A4 but not MDR1 single-nucleotide Polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients
D. R. J. Kuypers et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Unmasking the dynamic interplay between efflux transporters and metabolic enzymes
LZ Benet et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation
CE Staatz et al.
CLINICAL PHARMACOKINETICS (2004)
Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus
DA Hesselink et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Disposition of tacrolimus in isolated perfused rat liver: Influence of troleandomycin, cyclosporine, and GG918
CY Wu et al.
DRUG METABOLISM AND DISPOSITION (2003)
Therapeutic drug monitoring of inununosuppressant drugs in clinical practice
BD Kahan et al.
CLINICAL THERAPEUTICS (2002)
The effect of gut metabolism on tacrolimus bioavailability in renaltransplant recipients
S Tuteja et al.
TRANSPLANTATION (2001)
The gut as a barrier to drug absorption - Combined role of cytochrome P450 3A and P-glycoprotein
YC Zhang et al.
CLINICAL PHARMACOKINETICS (2001)
分享论文
